Molecular regulation of adipogenesis

Annual Review of Cell and Developmental Biology

Volumn 16, Issue , 2000, Pages 145-171

  Rosen, E D ^a   Spiegelman, B M ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Adipogenesis; Brown adipose tissue; Differentiation; White adipose tissue

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ADIPOCYTE; BROWN ADIPOSE TISSUE; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; DIABETES MELLITUS; HORMONAL REGULATION; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE; REVIEW; TRANSCRIPTION REGULATION; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADIPOSE TISSUE; ADIPOSE TISSUE, BROWN; ANIMALS; CELL DIFFERENTIATION; HORMONES; HUMANS; TRANSCRIPTION, GENETIC;

EID: 0034523640     PISSN: 10810706     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.cellbio.16.1.145     Document Type: Review

References (168)

1. Activators of peroxisome proliferator-activated receptor γ have depot-specific effects on human preadipocyte differentiation
2. Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site
3. Production of plasminogen activator 1 by human adipose tissue: Possible link between visceral fat accumulation and vascular disease
4. PPARγ induces cell cycle withdrawal: Inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A
5. Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors
6. Induction of the nuclear orphan receptor RORgamma during adipocyte differentiation of D1 and 3T3-L1 cells
7. PPAR gamma is required for placental, cardiac, and adipose tissue development
8. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension
9. Differentiation of 3T3 L1 fibroblasts to adipocytes induced by transfection of ras oncogenes
10. Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPAR delta ligands produce distinct biological effects
11. Regulation of E2F: A family of transcription factors involved in proliferation control
12. Increased level of mRNA for the uncoupling protein in brown adipose tissue of rats during thermogenesis induced by cold exposure or norepinephrine infusion
13. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-α, -β, and -γ in the adult rat
14. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat
15. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
16. Differential activation of adipogenesis by multiple PPAR isoforms
17. Regulation of peroxisome proliferator-activated receptor γ activity by mitogen-activated protein kinase
18. c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-γ1 and negatively regulates its transcriptional activity
19. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3 L1 cells
20. Terminal differentiation of mouse preadipocyte cells: The mitogen-adipogenic role of growth hormone is mediated by the protein kinase C signaling pathway
21. Evidence from in vitro differentiating cells that adrenoceptor agonists can increase uncoupling protein mRNA level in adipocytes of adult humans: An RT-PCR study
22. Analysis of gene expression during differentiation of adipogenic cells in culture and hormonal control of the developmental program
23. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs
24. Adipsin and an endogenous pathway of complement from adipose cells
25. Differentiation-induced gene expression in 3T3-L1 preadipocyte: CCAAT/enhancer-binding protein interacts with and activates the promoters of two adipocyte-specific genes
26. The role of C/EBP genes in adipocyte differentiation
27. Differentiation of human adipocyte precursors in a chemically defined serum-free medium
28. Adipose expression of the phosphoenolpyruvate carboxykinase promoter requires peroxisome proliferator-activated receptor gamma and 9-cis-retinoic acid receptor binding to an adipocyte-specific enhancer in vivo
29. Adipocyte precursor clones vary in capacity for differentiation
30. Lipoatrophic diabetes
31. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors
32. Reconstitution of insulin-sensitive glucose transport in fibroblasts requires expression of both PPAR gamma and C/EBP alpha
33. Constitutively active mitogen-activated protein kinase kinase 6 (MKK6) or salicylate induces spontaneous adipogenesis
34. Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis
35. Relationship between replication and differentiation in cultured human adipocyte precursor cells
36. The organization, promoter analysis, and expression of the human PPARγ gene
37. Regulation of peroxisome proliferator-activated receptor γ expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: Implications for adipocyte differentiation and metabolism
38. A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys
39. Mitogen-activated protein kinase activation is not necessary for, but antagonizes, 3T3-L1 adipocyte differentiation
40. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
41. 2 is a ligand for the adipocyte determination factor PPARγ
42. Ectopic expression of the CCAAT/enhancer binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells
43. Cachectin/tumor necrosis factor decreases human adipose tissue lipoprotein lipase mRNA levels, synthesis, and activity
44. Leptin and the regulation of body weight in mammals
45. Triiodothyronine and adipose conversion of OB17 preadipocytes: Binding to high affinity sites and effects on fatty acid synthesizing and esterifying enzymes
46. The mechanism of proton transport mediated by mitochondrial uncoupling proteins
47. Analysis of uncoupling protein and its mRNA in adipose tissue deposits of adult humans
48. Beta-adrenergic stimulation of brown adipocyte proliferation
49. Regulation of lipogenic enzyme gene expression by nutrients and hormones
50. Analysis of a tissue-specific enhancer: ARF6 regulates adipogenic gene expression
51. Sublines of mouse 3T3 cells that accumulate lipid
52. An established cell line and its differentiation in culture II. Factors affecting adipose conversion
53. Spontaneous heritable changes leading to increased adipose conversion in 3T3 cells
54. Formation of normally differentiated subcutaneous fat pads by an established preadipose cell line
55. A dual effector theory of growth-hormone activity
56. Understanding adipocyte differentiation
57. Emergence of brown adipocytes in white fat in mice is under genetic control
58. A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis
59. Increased obese mRNA expression in omental fat cells from massively obese humans
60. Effects of epidermal growth factor (EGF), platelet-derived growth factor (PDGF) and fibroblast growth factor (FGF) on human adipocyte development and function
61. The influence of human growth hormone on preadipocyte development in serum-supplemented and serum-free cultures of stromal-vascular cells from pig adipose tissue
62. The block of adipocyte differentiation by a C-terminally truncated, but not by full-length, simian virus 40 large tumor antigen is dependent on an intact retinoblastoma susceptibility protein family binding domain
63. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance
64. Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance
65. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ
66. Transdifferentiation of myoblasts by the adipogenic transcription factors PPARγ and C/EBPα
67. Functions of the retinoblastoma protein
68. The expression of tumor necrosis factor in human adipose tissue
69. Hormonal control of programmed cell death/apoptosis
70. Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1
71. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism
72. Dual DNA binding specificity of ADD1/SREBP1 controlled by a single amino acid in the basic helix-loop-helix domain
73. ADD1/SREBP1 activates PPARγ through the production of endogenous ligand
74. Age, anatomic site, and the replication and differentiation of adipocyte precursors
75. Enhancement of adipocyte differentiation by an insulin-sensitizing agent
76. 2 metabolite binds peroxisome proliferator-activated receptor g and promotes adipocyte differentiation
77. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
78. Norepinephrine-dependent selection of brown adipocyte cell lines
79. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance
80. Brown adipose tissue in patients with phaeochromocytoma
81. Depot-specific differences in adipose tissue gene expression in lean and obese subjects
82. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ)
83. Biological role of the CCAAT/enhancer-binding protein family of transcription factors
84. Antisense CCAAT/enhancer-binding protein RNA suppresses coordinate gene expression and triglyceride accumulation during differentiation of 3T3-L1 preadipocytes
85. CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program
86. Brown adipose tissue, β3-adrenergic receptors, and obesity
87. Regulation of fat and muscle development by transforming growth factor alpha in transgenic mice and in cultured cells
88. Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenic link between obesity and cardiovascular disease
89. Transcriptional regulation of gene expression during adipocyte differentiation
90. Expression of a constitutively activated form of protein kinase B (c-Akt) in 3T3-L1 preadipose cells causes spontaneous differentiation
91. Obese gene expression at in vivo levels by fat pads derived from s. c. implanted 3T3-F442A preadipocytes
92. Demonstration of de novo production of adipocytes in adult rats by biochemical and radioautographic techniques
93. Life without white fat: A transgenic mouse
94. Norepinephrine-induced lipolysis in rat fat cells from visceral and subcutaneous sites: Role of hormone-sensitive lipase and lipid droplets
95. Role of PPARγ in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c), and p21(Waf1/Cip1), during adipogenesis
96. The disease burden associated with overweight and obesity
97. Differential effects of fibroblast growth factor and tumor promoters on the initiation and maintenance of adipocyte differentiation
98. Prostacyclin as a potent effector of adipose-cell differentiation
99. Establishment of a preadipocyte clonal cell line from epididymal fat pad of ob/ob mouse that responds to insulin and to lipolytic hormones
100. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo Cushing's states
101. A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation
102. Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells
103. Regional differences in the control of lipolysis in human adipose tissue
104. A study of the adipose conversion of suspended 3T3 cells by using glycerophosphate dehydrogenase as a differentiation marker
105. The role of the CAAT/enhancer-binding protein in the transcriptional regulation of the gene for phosphoenolpyruvate carboxykinase (GTP)
106. Tumor necrosis factor-α prevents the differentiation of human adipocyte precursor cells and causes delipidation of newly developed fat cells
107. Transforming growth factor beta (TGF-beta) inhibits the differentiation of human adipocyte precursor cells in primary culture
108. Multilineage potential of adult human mesenchymal stem cells
109. Activation of ras by insulin in 3T3 L1 cells does not involve GTPase-activating protein phosphorylation
110. The timing of insulin/c-ras signal is critical for its effect upon the differentiation of C3H10T1/2-derived preadipocytes
111. Regulation of adipose cell number in man
112. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis
113. Role of insulin resistance in human disease
114. Expression of insulin receptors during preadipocyte differentiation
115. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor γ
116. DNA synthesis in mouse brown adipose tissue is under beta-adrenergic control
117. CREB activation induces adipogenesis in 3T3-L1 cells
118. Regulation and expression of retinoblastoma proteins p107 and p130 during 3T3-L1 adipocyte differentiation
119. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro
120. Tumor necrosis factor-α as a mediator of the insulin resistance of obesity
121. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase
122. Impaired fetal T cell development and perinatal lethality in mice lacking the cAMP response element binding protein
123. Retinoids are positive effectors of adipose cell differentiation
124. Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells
125. Anti-obesity effects of selective agonists to the beta 3-adrenergic receptor in dogs II. Recruitment of thermogenic brown adipocytes and reduction of adiposity after chronic treatment with a beta 3-adrenergic agonist
126. Adipose conversion of 3T3-L1 cells in a serum-free culture system depends on epidermal growth factor, insulin-like growth factor I, corticosterone, and cyclic AMP
127. The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation
128. Physiological role of epidermal growth factor on adipose tissue development in vivo
129. Peroxisome proliferator activated receptor gamma, CCAAT/enhancer-binding protein alpha, and cell cycle status regulate the commitment to adipocyte differentiation
130. Induction of preadipocyte differentiation by mature fat cells in the rat
131. Enhanced expression of PAI-1 in visceral fat: Possible contributor to vascular disease in obesity
132. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: Model for congenital generalized lipodystrophy
133. The orphan nuclear receptor estrogen-related receptor alpha is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene
134. Cleavage of membrane-associated pref-1 generates a soluble inhibitor of adipocyte differentiation
135. Transcriptional repression of pref-1 by glucocorticoids promotes 3T3-L1 adipocyte differentiation
136. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation
137. Insulin-like growth factor I is an essential regulator of the differentiation of 3T3-L1 adipocytes
138. Mitogen-activated protein kinase inhibits 1,25-dihydroxyvitamin D3-dependent signal transduction by phosphorylating human retinoid X receptor α
139. TGF-beta blocks early but not late differentiation-specific gene expression and morphologic differentiation of 3T3 T proadipocytes
140. Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes
141. PPARgamma ligand-dependent induction ofSTAT1, STAT5A, and STAT5B during adipogenesis
142. Regulation of signal transducers and activators of transcription (STATs) by effectors of adipogenesis: Coordinate regulation of STATs 1, 5A, and 5B with peroxisome proliferator-activated receptor-gamma and C/AAAT enhancer binding protein-alpha
143. Activation of the nuclear receptor peroxisome proliferator-activated receptor gamma promotes brown adipocyte differentiation
144. Defective adipocyte differentiation in mice lacking the C/EBPβ and/or C/EBPδ gene
145. Repressive effect of Sp1 on the C/EBPalpha gene promoter: Role in adipocyte differentiation
146. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine
147. CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP- 1/SDI-1) protein
148. Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPARγ and RXRα
149. PPARγ2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene
150. mPPARγ2: Tissue-specific regulator of an adipocyte enhancer
151. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
152. ADD1: A novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation
153. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor
154. CCAAT-enhancer binding protein: A component of a differentiation switch
155. The role of growth hormone/insulin-like growth factors in adipocyte differentiation
156. Impaired energy homeostasis in C/EBP alpha knockout mice
157. The fat organs of man: Development, structure, and systematic place of the so-called adipose tissue
158. A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation
159. Monoclonal antibodies against cell surface antigens expressed during porcine adipocyte differentiation
160. Induction of peroxisome proliferator-activated receptor γ during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPβ C/EBPδ, and glucocorticoids
161. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1
162. Cross-regulation of C/EBPα and PPARγ controls the transcriptional pathway of adipogenesis and insulin sensitivity
163. Conditional ectopic expression of C/EBPβ in NIH-3T3 cells induces PPARγ and stimulates adipogenesis
164. Cyclic AMP modulates adipogenesis in 3T3-F442A cells
165. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins
166. Positional cloning of the mouse obese gene and its human homologue
167. Structural organization of mouse peroxisome proliferator-activated receptor γ (mPPARγ) gene: Alternative promoter use and different splicing yield two mPPARγ isoforms